Fusion Antibodies plc announced that Sonya Ferguson, Non-executive Director, will not be seeking re-election at the AGM to be held on 27 October 2023, as she has decided to pursue another business opportunity. She will cease to be a Director of the Company at the close of the AGM.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.75 GBX | -1.32% | -1.32% | -11.76% |
May. 23 | Celadon ships to US; Oxford BioDynamics-Goodbody pact | AN |
May. 23 | Fusion Antibodies plc Announces New Contract with Existing Client Project to Develop Therapeutic | CI |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-11.76% | 4.55M | |
+43.36% | 54.64B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- FAB Stock
- News Fusion Antibodies plc
- Fusion Antibodies plc Announces Sonya Ferguson, Non-Executive Director, Will Not Be Seeking Re-Election At the AGM